Background. Although anxiety is prevalent in primary care, the association between anxiety symptoms and suicide risk remains understudied. Objectives. This cross-sectional study aimed to (i) assess the prevalence of suicide risk among Veteran primary care patients with anxiety symptoms and (ii) compare suicide risk between patients with a positive (versus negative) depression screen. Methods. Participants were 182 adult primary care patients (84.6% male, M age = 58.3 years) with current anxiety symptoms, but no psychotherapy in specialty care in the past year, at a Veterans Health Administration medical center in New York. Participants completed self-report measures of anxiety, depression and suicide risk via telephone. Results. Forty percent endorsed ≥1 suicide risk item. Suicide risk was more common among those screening positive (versus negative) for depression (50.5% versus 26.5%, χ 2 (1) = 10.88; P = 0.001). Participants with a negative depression screen constituted 31% of all those with any suicide risk. Logistic regression revealed that anxiety symptom severity was not associated with suicide risk (P = 0.14) after controlling for age, sex and depression screen status (P = 0.01). Conclusions. A substantial proportion of primary care patients with anxiety was classified as at risk for suicide, even in the absence of a positive depression screen. Primary care providers should assess suicide risk among patients with anxiety symptoms, even if the patients are not seeking specialty mental health treatment, the anxiety symptoms are not severe or do not rise to the level of an anxiety disorder, and comorbid depressive symptoms are not present.
Introduction
Primary care is an integral component of mental health care and suicide prevention. The identification of psychological symptoms associated with suicide risk may help to improve health care providers' detection of patients at risk for suicide. This study examined the association between anxiety symptoms and suicide risk in Veteran primary care patients who were not receiving psychotherapy in specialty care. This population warrants additional research because Veterans Health Administration (VHA) patients are at greater risk of suicide compared with the general US adult population (1) .
Whereas substantial research has identified depression as a risk factor for suicide (2) , the association between anxiety and suicide risk remains understudied (3) . This is a gap in the literature given that anxiety disorders are the most prevalent class of psychological disorders (4) and are especially common in primary care, with a point prevalence of up to 20% (5) . Subthreshold anxiety symptoms, which are clinically important (6) , are even more common than diagnostic-level anxiety disorders in primary care (7) .
Meta-analyses indicate that anxiety disorders are associated with greater odds of suicidal ideation and suicide attempts (8) . However, methodological limitations in the literature invite controversy regarding whether anxiety disorders are independently associated with suicide risk (3) . Much research is cross-sectional, and studies differ in whether and how they control for comorbidities. Some research (9, 10) has indicated that suicide risk was primarily driven by comorbid major depressive disorder (MDD) or posttraumatic stress disorder (PTSD). Other research has shown a strong link between anxiety disorders and suicidal ideation and/or attempts while controlling for comorbidities (11, 12) . Despite findings indicating a positive relationship between anxiety 'disorders' and suicide risk (8) , relatively little research has tested the association between anxiety 'symptoms' and suicide risk; furthermore, the few studies that have been conducted (13, 14) did not examine the adult primary care population.
Primary care is a key clinical setting for detecting suicide risk (15, 16) . Up to 12% of primary care patients endorse suicidal ideation (17) (18) (19) , with even higher prevalence among those with identified 'anxiety disorders' (20, 21) . Moreover, patients often present to primary care in the days and months preceding suicide attempts (22) .
Despite the probable link between anxiety and suicide risk, anxiety is often overlooked during suicide risk assessment in primary care. The focus tends to be on MDD and other mood disorders (23) , and identification of risk often occurs through depression screening (24) . For example, the VHA conducts universal screening in primary care patients, with follow-up suicide risk assessments based on positive screens for MDD and PTSD, but does not screen for any anxiety disorders (25) . Clinical guidelines (26) tend to emphasize the importance of assessing suicide risk in the presence of depression rather than anxiety. Thus, patients presenting to primary care with anxiety but no comorbid depressive symptoms may not receive adequate risk assessment, as health care providers may not recognize anxiety symptoms as a trigger to evaluate suicide risk.
Little is known about suicide risk among primary care patients with anxiety symptoms (not necessarily full-blown anxiety disorders), and the potential role of comorbid depressive symptoms is unclear (3) . Therefore, the objectives of the current study were to (i) assess the prevalence of suicide risk among a sample of Veteran primary care patients with anxiety symptoms and (ii) compare suicide risk between patients with a positive (versus negative) depression screen. We sampled Veterans due to the urgent need for improved suicide prevention in this population (1), and we sampled patients who were not receiving psychotherapy in specialty care because patients with anxiety are more likely to present to the primary care setting instead (27) . Better understanding of suicide risk among patients with anxiety symptoms would improve clinical guidance for providers in primary care who routinely encounter these patients.
Methods

Procedures
Participants were 182 primary care patients recruited from a VHA medical center in upstate New York between July 2014 and February 2015. The current study was embedded within a larger study on anxiety treatment preferences (28) . Inclusion criteria were (i) age 18 years or older; (ii) attended VHA primary care in the last year; (iii) history of anxiety diagnosis based on electronic medical record data and (iv) screened positive for current anxiety symptoms (i.e. past 2 weeks) on the Generalized Anxiety Disorder-7 (GAD-7). Exclusion criteria were (i) received psychotherapy in specialty care in the last year and (ii) cognitive or hearing impairment precluding informed consent or telephone screening, respectively. Patients were initially identified from the electronic medical record based on a prior history of an anxiety diagnosis but, given the potential for outdated or inaccurate diagnoses, were screened for current anxiety symptoms. We screened 628 Veterans, of which 210 (33.4%) were eligible; of those, 182 (86.7%) consented and completed the survey. Additional recruitment details and participant flow diagram for the larger study are reported elsewhere (28) . Eligible Veterans provided verbal informed consent and completed a 15-minute telephone survey assessing demographics, anxiety and depression symptoms, and suicide risk. Participants were compensated $5 for completing the survey. All study procedures were approved by the hospital's Institutional Review Board.
Measures
Anxiety symptoms
The GAD-7 self-report questionnaire was used to assess anxiety symptoms (29) . Respondents rate how much they have been bothered by specific anxiety symptoms over the last 2 weeks on a Likert scale from 0 (not at all) to 3 (nearly every day). The GAD-7 has good criterion validity and performs well as a screening tool for generalized anxiety disorder, social anxiety disorder and panic disorder (5). We used a cut-off score of ≥8 (5) for the inclusion criterion to ensure some level of anxiety symptoms. Total scores were classified as mild (8, 9) , moderate (10) (11) (12) (13) (14) and severe (15) (16) (17) (18) (19) (20) (21) per GAD-7 scoring conventions (29) .
Depressive symptoms
The Patient Health Questionnaire-2 (PHQ-2; (30)), the first two items from the PHQ-9 (31), was used to assess depressive symptoms. Respondents rate how much they have been bothered by low mood and anhedonia on a Likert scale from 0 (not at all) to 3 (nearly every day). Positive depression screens are indicated by total scores ≥3 (30) .
Suicide risk
The Suicidality Module from the MINI 5.0.0 (32) was used to assess suicide risk. Respondents indicate (yes/no) if they have (i) thought that they would be off dead or wished they were dead; (ii) thought about suicide; (iii) wanted to harm themselves; (iv) had a suicide plan; or (v) attempted suicide, in the past month, and (vi) ever made a suicide attempt. A scoring algorithm categorizes patients as low, moderate, or high risk for suicide (32) . This measure has convergent validity with clinician-administered suicide risk assessment and predictive validity for suicidal behaviour over 12 months (33) .
Data analyses
Descriptive statistics were calculated for anxiety symptoms and suicide risk for the entire sample and among groups based on a positive (versus negative) depression screen. We calculated 95% confidence intervals (CIs) for the suicide risk prevalence rates given our modest sample size (see Table 1 for CIs). A series of analysis of variance and chi-square tests was used to test for differences in anxiety symptoms and suicide risk based on depression screen status. To evaluate whether anxiety was associated with suicide risk beyond the contribution of comorbid depressive symptoms, multivariate logistic regression was conducted with any level of suicide risk (yes/no) as the dependent variable; anxiety symptom severity (mild, moderate, and severe) as the independent variable and depression screen status (positive, negative), age and sex (male, female) as covariates.
Results
Participants included 182 Veterans (M age = 58.3, SD = 14.9, range = 23-91). Age group distribution was 19.8% 18-44 years, 42.9% 45-64 years and 37.4% ≥65 years. The sample was predominately male (n = 154, 84.6%) and White (85.4% identified as White in parent study; 28).
The average GAD-7 score was 14.23 (SD = 3.68, range = 8-21), indicating anxiety symptoms of moderate severity. The modal symptom severity classification based on GAD-7 score was severe (46.2%), followed by moderate (41.2%) and mild (12.6%). The average PHQ-2 score was 2.96 (SD = 1.75, range = 0-6), and 54.4% screened positive for depression. GAD-7 and PHQ-2 scores were positively correlated (r = 0.52; P < 0.001).
Prevalence of endorsed suicide risk items among entire sample Table 1 displays the proportion of participants who endorsed each suicide risk item; although no participants reported a suicide attempt in the past month, 20.0% reported a lifetime suicide attempt, and 1 in 7 reported suicidal ideation in the past month. Overall, 60.4% of participants did not endorse any suicide risk items. The 39.6% who endorsed one or more suicide risk items were classified (based on the scoring algorithm) as being at low (23.6% of entire sample), moderate (6.0%) or high (9.9%) risk for suicide.
Group differences in anxiety and suicide risk based on depression screen status On average, Veterans who screened positive for depression reported severe anxiety symptoms (m = 15.62, SD = 3.46) and those who screened negative for depression reported moderate anxiety symptoms (m =12.59, SD = 3.27), [F(180) = 36.23, P < 0.001]. Any level of suicide risk was more common among patients who screened positive for depression compared with those who screened negative for depression (50.5% versus 26.5%, χ 2 = 10.88, P = 0.001). In terms of specific suicide risk items (see Table 1 ), only past month non-suicidal morbid ideation was more common among those who screened positive versus negative for depression (37.4% versus 9.6%, χ 2 = 18.66, P < 0.0001).
The full logistic regression model predicted suicide risk, χ 
Suicide risk among those with anxiety symptoms and a negative depression screen
Among Veterans with anxiety symptoms and a negative depression screen, approximately one in eight reported thoughts of suicide in the past month (see Table 1 ). Overall, 73.5% (n = 61) of Veterans with anxiety symptoms and a negative depression screen did not endorse any suicide risk items. However, 26.5% of these participants (n = 22), which constituted 31% of all those with any level of suicide risk, with anxiety symptoms and a negative depression screen did have some level of suicide risk. Of these 22 participants, 11 were classified as low risk, 5 as moderate risk and 6 as high risk for suicide.
Discussion
In this sample of Veterans with anxiety symptoms recruited from primary care, morbid ideation, suicidal ideation and prior suicide attempts were common, with 40% of patients having elevated risk for suicide. This study extends previous research on suicide risk among primary care patients with anxiety disorders (20, 21) to patients with current anxiety symptoms (not necessarily disorders). The focus on patients based on symptoms matches real-world primary care conditions, in which health care providers are likely to identify the presence of anxiety symptoms, but not know if patients meet diagnostic criteria for anxiety disorders. Shifting our focus from diagnoses to symptoms (34) and increasing attention to anxiety (15) may help to improve suicide prevention in primary care by identifying more patients who are at elevated suicide risk. Although the risk of suicide was heightened among those patients with anxiety symptoms who screened positive for depression and Positive depression screen defined as score ≥3 on Patient Health Questionnaire-2 (PHQ-2). b Two participants declined to answer this item, so n for full sample was 180 and n for positive depression screen was 97.
C P < 0.05.
anxiety symptom severity was not significantly associated with suicide risk after controlling for depression screen status, over onequarter of Veterans with current anxiety symptoms who screened negative for depression had at least some level of suicide risk. Specifically, thoughts about suicide and lifetime suicide attempt were endorsed by 12.0% and 18.1%, respectively, which is similar to prior research in primary care patients seeking treatment for anxiety disorders (21) . Future research should examine the relationship between anxiety and suicide risk in larger samples displaying a full range of symptom severity (i.e. including participants with no, minimal and mild symptoms). The overall prevalence of past month suicidal ideation (14.3%) in this sample was higher than the prevalence of suicidal ideation found in one primary care study (2.4%; 17) but similar to another (11.8%; 19). The prevalence of any suicide risk (39.6%) in this sample was higher than that found in a sample of VHA patients from four primary care clinics (9.1%; 18), but this difference is likely due to our sample being recruited based on the presence of anxiety symptoms. Indeed, the prevalence of suicidal ideation and overall risk in our sample is consistent with the rates found in prior research sampling primary care patients either with current anxiety disorders (21) or being referred for evaluation after a positive mental health screen (35) . These prevalence rates underscore the notion that primary care is a key setting for suicide prevention efforts.
Consistent with previous research in primary care (17, 18) , suicide risk was especially common among those who screened positive for depression. Furthermore, depression screen status was independently associated with suicide risk when controlling for anxiety severity. Research has shown that patients with the combination of anxiety and depression together report greater distress and worse outcomes compared with patients with either anxiety or depression alone (36) . The same pattern holds when examining suicide risk among patients with comorbid anxiety and depressive disorders compared with either type of disorder alone (37) . Thus, screening primary care patients for depression remains an important part of suicide prevention efforts (25, 26) , and health care providers in primary care should be especially attuned to the need for suicide risk assessment among patients reporting symptoms of both depression and anxiety.
Clinical implications
The primary clinical implication of current findings is that primary care providers (PCPs) should consider assessing suicide risk among patients presenting with anxiety symptoms, irrespective of the severity of anxiety symptoms or the presence of comorbid depressive symptoms. Expanding routine suicide risk screening/assessment to include patients with anxiety symptoms would likely increase the sensitivity of detection, resulting in a greater proportion of patients who are at elevated risk for suicide receiving appropriate follow-up. Indeed, our results suggest that doing so would detect more individuals who were not seeking any mental health treatment despite having current mental health symptoms as well as thoughts of suicide or a prior suicide attempt. Together with prior research (21) , findings suggest that health care providers in primary care should employ suicide risk screening and/or assessment with patients across the range of anxiety symptom severity.
Study limitations and strengths
The results of this study should be considered in light of study limitations, which suggest directions for future research. First, the crosssectional design precludes any causal interpretations regarding the association between anxiety symptoms and suicide risk. Prospective research is needed to examine the longitudinal association between anxiety symptoms and suicidal ideation and behaviour. Second, the sample comprised Veterans attending primary care at a single VHA hospital and was mostly White and male. Although the gender and racial/ethnic distribution of the sample were representative of patients at the study site and within VHA, our findings may not generalize to more diverse samples or to non-Veterans. Future research should target larger samples from a variety of sites, both within and outside (e.g. civilians) of VHA as well as military Veterans in other countries. Notably, the minimum GAD-7 score in our sample was 8 rather than 0 due to our eligibility criteria, and the majority of participants reported moderate to severe symptoms; this restricted range may have influenced our findings. The GAD-7 is one measure of anxiety symptom severity focused on a 2-week period, and it is unknown whether participants met criteria for an anxiety disorder. Given its brevity, the PHQ-2 has reduced sensitivity; this measure may also pick up negative affect associated with PTSD, which is prevalent in Veterans (38) , so future research should assess PTSD as well as anxiety and depressive symptoms. Finally, self-selection bias with the sample is always possible in research, as patients who declined to participate in the study may be less comfortable reporting, or even less likely to have experienced, mental health symptoms such as anxiety or suicidal ideation.
Despite a modest sample size and the above-noted limitations, this study had numerous strengths. Much of the literature on suicide risk has focused on patients engaged in mental health treatment (39) . The current study extends prior research by examining primary care patients, specifically those not seeking specialty mental health treatment. We have focused on a population for whom PCPs in family practice can have significant clinical impact and thereby improve the quality of primary care and suicide prevention for those with mental health concerns. We identified the sample based on anxiety symptoms, rather than disorders, and used the GAD-7, which is widely used in primary care, to better match real-world primary care practice conditions. Patients with subthreshold or mild symptoms are most likely to present to primary care settings (6) , which offers an opportunity to detect patients who may be at risk for suicide. We assessed suicide risk contemporaneously upon establishing the presence of current anxiety symptoms to capture patients at a key point in time. Finally, our measure of suicide risk assessed multiple risk factors including plans and prior attempts, which improves upon previous research in primary care that was limited to assessment of suicidal ideation (7, 19) .
Conclusions
The current results indicate that a substantial proportion of primary care patients with anxiety are at elevated risk for suicide even in the absence of a positive depression screen. These findings extend previous research to patients not seeking specialty mental health treatment and to those with anxiety symptoms that may not meet full diagnostic criteria for an anxiety disorder. PCPs should consider assessing suicide risk among primary care patients with anxiety symptoms, even if symptoms are subthreshold or mild, there are no comorbid depressive symptoms and specialty mental health treatment is not being sought. By doing so, PCPs can help to improve suicide detection and prevention.
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